|
New publication
|
11
|
Resverlogix Corp.
|
Sep 21, 2019 05:39PM
|
|
Re: Agm
|
10
|
Resverlogix Corp.
|
Dec 14, 2017 09:02AM
|
|
Re: RVX AGM 171212 - Rough Transcription - Not proofed or edited. Feel free to correct.
|
10
|
Resverlogix Corp.
|
Dec 14, 2017 11:05AM
|
|
Phase 1 Renal Trial Completed
|
10
|
Resverlogix Corp.
|
Sep 20, 2016 06:45AM
|
|
Collection of ERA-EDTA and ESC Resverlogix Sponsored Symposia Videos
|
10
|
Resverlogix Corp.
|
Aug 15, 2019 02:38PM
|
|
AHA 2020
|
10
|
Resverlogix Corp.
|
Sep 17, 2020 11:18AM
|
|
ASN late breaker and CKD sub-study top-line
|
10
|
Resverlogix Corp.
|
Oct 09, 2019 07:05PM
|
|
Re: Re San fran
|
10
|
Resverlogix Corp.
|
Oct 19, 2020 11:30AM
|
|
Re: Pointing in the right direction & bogus Lilly
|
10
|
Resverlogix Corp.
|
Jun 21, 2018 11:03AM
|
|
Re: Vaccine
|
10
|
Resverlogix Corp.
|
Nov 16, 2020 10:31AM
|
|
Re: Statistical Considerations
|
10
|
Resverlogix Corp.
|
Mar 06, 2018 02:22PM
|
|
Clarification on BETonMACE baseline data
|
10
|
Resverlogix Corp.
|
Sep 04, 2019 12:43PM
|
|
Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
10
|
Resverlogix Corp.
|
Feb 02, 2018 11:00AM
|
|
Re: The chart set up looks awesome imo....
|
10
|
Resverlogix Corp.
|
Dec 03, 2019 02:10PM
|
|
Re: CTAD Asia Alzheimer's Conference Sept 1 & 2
|
10
|
Resverlogix Corp.
|
Sep 01, 2018 09:31AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
10
|
Resverlogix Corp.
|
Jul 15, 2019 10:25AM
|
|
The Evolution of Apabetalone, Redux
|
10
|
Resverlogix Corp.
|
Apr 26, 2019 04:06PM
|
|
Re: Upcoming PR
|
10
|
Resverlogix Corp.
|
Jul 03, 2019 08:06PM
|
|
Seeking Alpha articles
|
10
|
Resverlogix Corp.
|
Aug 05, 2017 11:27AM
|
|
Re: AHA late breaking abstract
|
10
|
Resverlogix Corp.
|
Nov 11, 2019 09:36AM
|
